A leader in allergen immunotherapy

With more than a century of expertise in allergies and allergen immunotherapy (AIT), Stallergenes Greer is a leader in its field.

Stallergenes Greer, a fully integrated global biopharmaceutical company, specialises in the diagnosis and treatment of allergies through the research, development and commercialisation of AIT products and services for respiratory and food allergies.

The company’s product portfolio, which covers a broad range of administration modes (subcutaneous, sublingual drops and tablets for respiratory allergies, and powder to be consumed with semi-solid foods for peanut allergies), offers healthcare professionals innovative, safe and effective solutions to improve life for people with allergies.

About allergen immunotherapy

Allergen immunotherapy (AIT) is an allergy treatment designed to treat the underlying cause of the disease as well as have a carry-over effect on all symptoms. After an accurate diagnosis of the type of allergy and responsible allergens, patients, in line with their healthcare practitioner’s prescription, receive a targeted treatment. Through the repeated administration of specific allergens, the immune system builds resistance¹ thus reducing symptoms when patients are exposed to the allergen in their environment.

Learn more about the Stallergenes Greer group

¹ Global Atlas of Allergy, EAACI 2014